Patent holdings for IPC class C07D 271/07

Total number of patents in this class: 165

10-year publication summary

13
22
15
10
15
10
6
15
10
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
460
6
Farmington Pharma Development
7
5
Oryzon Genomics S.A.
106
5
Novassay S.A.
10
4
Romark Laboratories L.C.
52
4
Janssen Pharmaceutica N.V.
3396
3
Bayer Intellectual Property GmbH
2509
3
Bayer Cropscience AG
2051
3
Bayer Pharma AG
1061
3
King Faisal University
908
3
The Board of Regents of the University of Texas System
2204
3
Calico Life Sciences LLC
96
3
Merck Sharp & Dohme LLC
3751
3
Bristol-myers Squibb Company
4879
2
BASF SE
20892
2
Boehringer Ingelheim International GmbH
4697
2
Abbvie Inc.
1800
2
Takeda Pharmaceutical Company Limited
2712
2
Vertex Pharmaceuticals Incorporated
1595
2
Northwestern University
3374
2
Other owners 103